Skip to main content
. 2020 Nov 17;11:554249. doi: 10.3389/fmicb.2020.554249

TABLE 3.

Comparisons of clinical and microbiological characteristics between FS and FNS, FNS CC2 and Other FNS C. tropicalis infections, Wuhan.

Characteristic FS Infection (n = 49) FNS Infection (n = 35) P-value FNS CC2 Infection (n = 13) Other FNS Infection (n = 22) P-value
Demographics
Age, y, median (IQR) 55.0 (37.0–67.0) 57.0 (44.5–76.5) 0.19 63.0 (56.0–82.0) 55.0 (44.3–73.8) 0.35
Sex n (%) 0.48 0.72
M 22 (44.9) 13 (37.1) 4 (30.8) 9 (40.9)
F 27 (55.1) 22 (62.9) 9 (69.2) 13 (59.1)
Comorbid conditionsan (%)
Heart disease 9 (18.4) 14 (40.0) 0.03* 4 (30.8) 10 (45.5) 0.49
Lung diseases 16 (32.7) 17 (48.6) 0.14 9 (69.2) 8 (36.4) 0.09
Hepatobiliary/pancreatic diseases 10 (20.4) 10 (28.6) 0.39 4 (30.8) 6 (27.3) 1.00
Kidney disease 10 (20.4) 13 (37.1) 0.09 6 (46.2) 7 (31.8) 0.48
Brain diseases 9 (18.4) 11 (31.4) 0.17 4 (30.8) 7 (31.8) 1.00
Solid tumor 4 (8.2) 7 (20.0) 0.21 4 (30.8) 3 (13.6) 0.38
Diabetes 9 (18.4) 4 (11.4) 0.39 1 (7.7) 3 (13.6) 1.00
Hypertension 13 (26.5) 14 (40.0) 0.19 6 (46.2) 8 (36.4) 0.72
Gynecological disease 15 (30.6) 6 (17.1) 0.16 2 (15.4) 4 (18.2) 1.00
Healthcare factors n (%)
Solid-organ transplant 1 (2.0) 0 1.00 0 0
Surgery 12 (24.5) 9 (25.7) 0.90 5 (38.5) 4 (18.2) 0.24
Mechanical ventilator 13 (26.5) 14 (40.0) 0.19 7 (53.8) 7 (31.8) 0.29
Indwelling urinary catheter 18 (36.7) 18 (51.4) 0.18 8 (61.5) 10 (45.5) 0.49
Central venous catheter 12 (24.5) 13 (37.1) 0.21 6 (46.2) 7 (31.8) 0.48
Antifungal drug exposure 6 (12.2) 11 (31.4) 0.03* 4 (30.8) 7 (31.8) 1.00
Antimicrobial drug exposure 38 (77.6) 28 (80.0) 0.79 11 (84.6) 17 (77.3) 0.69
Primary infection sites n (%)
Bloodstream infection 7 (14.3) 6 (17.1) 0.72 2 (15.4) 4 (18.2) 1.00
Visceral infection 3 (6.1) 2 (5.7) 1.00 1 (7.7) 1 (4.5) 1.00
Urinary tract infection 20 (40.8) 20 (57.2) 0.14 8 (61.5) 12 (54.6) 0.74
Respiratory tract infection 3 (6.1) 1 (2.9) 0.86 1 (7.7) 0 0.37
Reproductive tract infection 16 (32.7) 6 (17.1) 0.11 1 (7.7) 5 (22.7) 0.38
Wards n (%)
ICU/RICU 8 (16.3) 7 (20.0) 0.67 2 (15.4) 5 (22.7) 0.69
Gynecology/Reproductive 16 (32.7) 7 (20.0) 0.20 1 (7.7) 6 (27.3) 0.22
Surgeryb 19 (38.8) 9 (25.7) 0.21 4 (30.8) 5 (22.7) 0.70
Medicalc 6 (12.2) 12 (34.3) 0.02* 6 (46.1) 6 (27.3) 0.29
Death n (%)
All 6 (12.2) 10 (28.6) 0.06 3 (23.1) 7 (31.8) 0.71
With pulmonary candidiasisd 1 (33.3) 1 (100.0) 1.00 1 (100.0) 0
With candidemiae 1 (14.3) 3 (50.0) 0.27 1 (50.0) 2 (50.0) 1.00
With candidiuriaf 4 (20.0) 6 (30.0) 0.47 1 (12.5) 5 (41.7) 0.33

aAll systemic diseases were not graded, including mild-severe infection, mild organ dysfunction-severe organ failure.

bSurgery wards: including Urology ward, Pancreatic ward, Hepatobiliary ward, Cardiovascular Surgery ward, Neurosurgery ward, Transplantation ward, and Interventional ward.

cMedical wards: including Geriatric ward, Oncology ward, neurology ward, Cardiovascular Medicine ward, Endocrinology ward, Hematology ward, and Nephrology ward.

dWith pulmonary candidiasis: A total of 4 cases. FS Infection (n = 3), FNS Infection (n = 1); FNS CC2 Infection (n = 1), Other FNS Infection (n = 0). There was only 1 case of pulmonary Candida infection with FNS C. tropicalis (in CC2), which could not be compared in groups (FNS CC2 Infection group and Other FNS Infection group), so the P-value was shown as “−”.

eWith candidemia: A total of 13 cases. FS Infection (n = 7), FNS Infection (n = 6); FNS CC2 Infection (n = 2), Other FNS Infection (n = 4).

fWith candidiuria: A total of 40 cases. FS Infection (n = 20), FNS Infection (n = 20); FNS CC2 Infection (n = 8), Other FNS Infection (n = 12).

*P<0.05, the difference was statistically significant.